Enterprise AI · Pharma · Biotech · Healthcare Intelligence

See the next move in neuroscience before the market does.

NeuroRisk.ai connects clinical trials, sponsors, institutions, scientific evidence, country signals and market forecasts into one evidence-linked intelligence system for pharma, biotech, investors, hospitals and governments.

Request Enterprise Demo → Explore Company Intelligence

Priority Markets

United States92

Australia87

Canada86

Germany85

China84

France82

Japan81

Netherlands81

clinical corpus12,998Mapped trial records in the restored intelligence corpus

live sponsor layer454Sponsors currently represented in sponsor intelligence

institutions2,723Research institutions in the current intelligence layer

authors10,419Research authors represented in the current graph

OpenAlex works897Works in the current OpenAlex intelligence layer

global18Priority country intelligence profiles

forecast2030Strategic forecast horizon

EnterpriseCompany IntelligenceSponsors, pipelines, trial activity, therapeutic exposure and competitive signals.ClinicalTrial IntelligenceGlobal trial activity, sponsors, phases, recruitment and evidence-linked signals.ResearchInstitution Intelligence2,723 institutions, 10,419 authors and scientific network intelligence.StrategyCompetitive IntelligenceConnect companies, diseases, markets, research momentum and forecasts.AIAI Decision IntelligenceEvidence-grounded synthesis designed for enterprise research and strategy workflows.DataEnterprise Data PlatformAPIs, provenance, knowledge graph and continuously refreshed intelligence layers.

Built for decisions worth billions.

Portfolio strategy, competitive intelligence, clinical development, business development, investment screening, research partnerships and market prioritization — connected to evidence rather than isolated dashboards.

Request Enterprise Access → Explore Enterprise API Security & Compliance